1. Devi N, Narayanan G, Lakshmi S, Nair S, Prakash NP (2018) Estimation of plasma EBV DNA levels in Hodgkin’s Lymphoma and its correlation with treatment response. Indian J Hematol Blood Transfus 34(Suppl 1):S353
2. Kumar AS, Epari S, Gupta S, Sengar M, Jain H, Shet T (2018) Marrow involvement in Hodgkin’s Lymphoma: pathology findings in a fading disease. Indian J Hematol Blood Transfus 34(Suppl 1):S347
3. Korula A, Fouzia NA, Devasia A, Kulkarni U, Abraham A, Srivastava A, George B, Mathews V (2018) Impact of imaging modality on clinical outcome in hodgkin lymphoma in a resource constrained setting. Indian J Hematol Blood Transfus 34(Suppl 1):S59
4. Siddiqui S, Kapoor J, Singh R, Agrawal N, Mehta P, Thekkudan SF, Garg A, Bhurani D, Ahmed R (2018) Absolute lymphocyte count/absolute monocyte count may determine prognosis in diffuse large B-cell lymphoma. Indian J Hematol Blood Transfus 34(Suppl 1):S350–S351
5. Chawla M, Dhar SK, Saha B, Venkata M, Das M, Nayak M, Damodar S, Badiger S, Bhat S, Nataraj KS (2018) Expression of Programmed Cell Death Ligand1 (PDL1) and Programmed Cell Death1 (PD1) in patients with Diffuse Large B Cell Lymphoma (DLBCL): an Indian Study. Indian J Hematol Blood Transfus 34(Suppl 1):S338–S339